Skip to content

Agkistrodon different formulations inflammatory and analgesic effects on rheumatoid arthritis clinical study

Agkistrodon different formulations inflammatory and analgesic effects on rheumatoid arthritis clinical study

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-13003578
Enrollment
Unknown
Registered
2013-09-09
Start date
2013-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

The water decoction group of Agkistrodon:Taking the water decoction of Agkistrodon
Agkistrodon liquor:Taking Agkistrodon liquor agents
Agkistrodon pulvis:Taking the Agkistrodon pulvis

Sponsors

Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the 2010 ACR / EULAR classification criteria for rheumatoid arthritis; (2) Belong to the early RA, and in arthritis attack, no significant joint deformity; (3) Aged 18 to 65 years old; (4) Within a month before the test is not used by traditional Chinese medicine; (5) Methotrexate indications meet application; (6) Voluntarily agree to participate in this experiment and clinical study signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Stable condition, the onset of RA patients without arthritis; (2) WBC<3×10^9/L; (3) With secondary or primary cardiovascular, brain, lung, liver, kidney, hematopoietic system, digestive system and other target organ damage were fatal; (4) Pregnant women, lactating women, the mentally ill; (5) Allergies and multiple drug allergies, contraindications methotrexate has applications.

Design outcomes

Primary

MeasureTime frame
ESR;CRP;RF;routine blood test;DAS28-3;VAS Pain score;ACR classification of joint function;HAQ Health Assessment Questionnaire;

Secondary

MeasureTime frame
Liver and kidney function;

Countries

China

Contacts

Public ContactXie Zhijun

Zhejiang Chinese Medical University

xzj575@163.com+86 13757132498

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026